PL3720496T3 - Stały doustny preparat nikotynowy - Google Patents
Stały doustny preparat nikotynowyInfo
- Publication number
- PL3720496T3 PL3720496T3 PL18821993.5T PL18821993T PL3720496T3 PL 3720496 T3 PL3720496 T3 PL 3720496T3 PL 18821993 T PL18821993 T PL 18821993T PL 3720496 T3 PL3720496 T3 PL 3720496T3
- Authority
- PL
- Poland
- Prior art keywords
- solid oral
- nicotine formulation
- oral nicotine
- formulation
- solid
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960002715 nicotine Drugs 0.000 title 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201770926 | 2017-12-08 | ||
| PCT/DK2018/050336 WO2019110073A1 (en) | 2017-12-08 | 2018-12-07 | Solid oral nicotine formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3720496T3 true PL3720496T3 (pl) | 2025-04-28 |
Family
ID=64744344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18821993.5T PL3720496T3 (pl) | 2017-12-08 | 2018-12-07 | Stały doustny preparat nikotynowy |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190174812A1 (https=) |
| EP (2) | EP4512474A3 (https=) |
| JP (1) | JP7398374B2 (https=) |
| CN (1) | CN111432840B (https=) |
| AU (1) | AU2018378649B2 (https=) |
| BR (1) | BR112020011238A2 (https=) |
| CA (1) | CA3085063C (https=) |
| DK (1) | DK3720496T3 (https=) |
| ES (1) | ES3015556T3 (https=) |
| FI (1) | FI3720496T3 (https=) |
| MX (1) | MX2020005892A (https=) |
| PL (1) | PL3720496T3 (https=) |
| WO (1) | WO2019110073A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3085065C (en) | 2017-12-08 | 2023-12-05 | Fertin Pharma A/S | Formulations providing high nicotine concentrations |
| WO2019110072A1 (en) | 2017-12-08 | 2019-06-13 | Fertin Pharma A/S | Nicotine tablet |
| SE1951054A1 (en) * | 2019-09-18 | 2021-03-19 | Enorama Pharma Ab | Nicotine pouch |
| RS64944B1 (sr) * | 2019-11-20 | 2024-01-31 | Swedish Match North Europe Ab | Nikotinski proizvod u kesici za oralnu upotrebu koji uključuje punjenje koje sadrži čestice nikotina |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| JP2023504756A (ja) | 2019-12-09 | 2023-02-06 | ニコベンチャーズ トレーディング リミテッド | カンナビノイドを含む口腔用製品 |
| US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| US12520867B2 (en) | 2019-12-09 | 2026-01-13 | Nicoventures Trading Limited | Buffered oral compositions |
| CA3181912A1 (en) | 2020-06-08 | 2021-12-16 | Anthony Richard Gerardi | Effervescent oral composition comprising an active ingredient |
| WO2022103639A1 (en) * | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs |
| CN112237295B (zh) * | 2020-11-16 | 2022-03-25 | 云南中烟工业有限责任公司 | 一种高持液力透明固体烟油 |
| US11382861B1 (en) * | 2020-12-17 | 2022-07-12 | Nirajkumar Karneshbhai Patel | Nicotine pouch |
| GB202105305D0 (en) * | 2021-04-14 | 2021-05-26 | Zanoprima Lifesciences Ltd | Supported nicotine composition |
| MX2023015529A (es) | 2021-06-25 | 2024-03-05 | Nicoventures Trading Ltd | Productos orales y metodo de fabricacion. |
| JP2024530905A (ja) | 2021-07-30 | 2024-08-27 | ニコベンチャーズ トレーディング リミテッド | 微結晶性セルロースを含むエアロゾル生成基材 |
| CA3233375A1 (en) | 2021-09-30 | 2023-04-06 | Michael Zawadzki | Oral product with a basic amine and an ion pairing agent |
| MX2024003997A (es) * | 2021-09-30 | 2024-06-04 | Nicoventures Trading Ltd | Composicion de goma oral. |
| US11786473B2 (en) * | 2021-12-14 | 2023-10-17 | Fertin Pharma A/S | Nicotine tablet |
| US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
| MX2023009660A (es) * | 2022-03-22 | 2023-10-04 | Poviva Corp | Composiciones y metodos para la administracion sublingual de nicotina. |
| CA3246974A1 (en) | 2022-04-01 | 2023-10-05 | EMPLICURE AB (publ) | ALKALINE INTRAORAL PRODUCTS |
| GB2620110B (en) * | 2022-06-15 | 2025-08-13 | Emplicure Ab Publ | Alkaline intraoral products |
| KR20250011902A (ko) | 2022-04-01 | 2025-01-22 | 엠플리큐어 아베 (퍼블릭) | 니코틴 제제 |
| JP2025513763A (ja) | 2022-04-01 | 2025-04-30 | エンプリキュア アクチエボラゲット（ピーユービーエル） | 口腔内用製剤、透過性密封バッグ、錠剤、方法、及びその使用 |
| DK181772B1 (en) * | 2023-02-03 | 2024-12-10 | Fertin Pharma As | A nicotine pouched product |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248760B1 (en) * | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
| US6583160B2 (en) * | 1999-04-14 | 2003-06-24 | Steve Smith | Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| US6544552B2 (en) * | 2001-01-11 | 2003-04-08 | Particle And Coating Technologies, Inc. | Method of producing porous tablets with improved dissolution properties |
| NZ530439A (en) * | 2001-04-20 | 2004-11-26 | Lavipharm Lab Inc | Intraoral delivery of nicotine for smoking cessation |
| US20070269386A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
| CL2009001025A1 (es) * | 2008-05-01 | 2010-09-24 | Smithkline Beecham Corp | Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. |
| SI2177213T1 (sl) * | 2008-09-17 | 2013-03-29 | Siegfried Ltd. | Nikotin vsebujoč granulat |
| ES2592882T3 (es) | 2008-10-14 | 2016-12-02 | Mcneil Ab | Forma de dosificación intra-oral de múltiples porciones y uso de la misma |
| WO2013091631A1 (en) * | 2011-12-22 | 2013-06-27 | Fertin Pharma A/S | Method of releasing nicotine from chewing gum |
| US20130177646A1 (en) * | 2012-01-05 | 2013-07-11 | Mcneil Ab | Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
| DK3166563T3 (da) * | 2014-07-08 | 2021-02-15 | Fertin Pharma As | Oralt administrationssystem omfattende to rum |
| US20170165252A1 (en) * | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
-
2018
- 2018-12-07 WO PCT/DK2018/050336 patent/WO2019110073A1/en not_active Ceased
- 2018-12-07 EP EP24220229.9A patent/EP4512474A3/en active Pending
- 2018-12-07 AU AU2018378649A patent/AU2018378649B2/en active Active
- 2018-12-07 US US16/213,678 patent/US20190174812A1/en not_active Abandoned
- 2018-12-07 FI FIEP18821993.5T patent/FI3720496T3/fi active
- 2018-12-07 DK DK18821993.5T patent/DK3720496T3/da active
- 2018-12-07 EP EP18821993.5A patent/EP3720496B1/en active Active
- 2018-12-07 MX MX2020005892A patent/MX2020005892A/es unknown
- 2018-12-07 PL PL18821993.5T patent/PL3720496T3/pl unknown
- 2018-12-07 CA CA3085063A patent/CA3085063C/en active Active
- 2018-12-07 CN CN201880079278.9A patent/CN111432840B/zh active Active
- 2018-12-07 JP JP2020531151A patent/JP7398374B2/ja active Active
- 2018-12-07 BR BR112020011238-0A patent/BR112020011238A2/pt unknown
- 2018-12-07 ES ES18821993T patent/ES3015556T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN111432840A (zh) | 2020-07-17 |
| RU2020122405A3 (https=) | 2022-01-13 |
| CN111432840B (zh) | 2023-10-20 |
| EP4512474A2 (en) | 2025-02-26 |
| BR112020011238A2 (pt) | 2021-01-05 |
| AU2018378649B2 (en) | 2021-06-03 |
| DK3720496T3 (en) | 2025-03-17 |
| EP3720496A1 (en) | 2020-10-14 |
| EP4512474A3 (en) | 2025-04-23 |
| JP7398374B2 (ja) | 2023-12-14 |
| JP2021505617A (ja) | 2021-02-18 |
| CA3085063C (en) | 2024-05-21 |
| WO2019110073A1 (en) | 2019-06-13 |
| EP3720496B1 (en) | 2025-02-05 |
| MX2020005892A (es) | 2020-10-07 |
| ES3015556T3 (en) | 2025-05-06 |
| CA3085063A1 (en) | 2019-06-13 |
| RU2020122405A (ru) | 2022-01-13 |
| US20190174812A1 (en) | 2019-06-13 |
| FI3720496T3 (fi) | 2025-03-05 |
| AU2018378649A1 (en) | 2020-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3720496T3 (en) | Solid oral nicotine formulation | |
| SG11202011761XA (en) | Nicotine formulation | |
| IL273541A (en) | formulations | |
| ZA201903452B (en) | Oral care compositions | |
| IL273282A (en) | Niraprib formulations | |
| IL269630A (en) | Niraprib formulations | |
| IL269621A (en) | Niraparib formulations | |
| IL257658B (en) | compounds for oral care | |
| IL270812A (en) | Solid compositions for oral drug administration | |
| ZA201903460B (en) | Oral care compositions | |
| IL257659B (en) | Oral care compositions | |
| ZA201807730B (en) | An oral care composition | |
| ZA201807771B (en) | Oral care compositions | |
| ZA201903431B (en) | Oral care compositions | |
| ZA201901982B (en) | Oral care compositions | |
| IL262745A (en) | Improved preparations containing drugs | |
| ZA201903379B (en) | Oral care compositions | |
| ZA201902622B (en) | Oral care composition | |
| ZA201902623B (en) | Oral care composition | |
| ZA201903430B (en) | Oral care compositions | |
| ZA201903451B (en) | Oral care compositions | |
| HUE064843T2 (hu) | Orális oldat kiszerelés | |
| SG11201710708VA (en) | Oral composition | |
| ZA202004108B (en) | Oral care composition | |
| IL273644A (en) | Formulations of bendamustine for oral administration |